| P/E (FY) | — | Sales (TTM) | NOK 27.9M |
| Earnings (TTM) | -NOK 60.4M | ROE | −47.55% |
| Net Margin | −216.03% | ROIC | −24.78% |
| Debt / Equity | 0.47 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 111.32% |
Observe Medical ASA develops and commercializes medical technology products for patients, clinicians, and hospitals in Europe, Asia, and the Americas. Its UnoMeter range, including Safeti Plus and UnoMeter AbdoPressure, is used for manual urine output measurement and for gauging intra-abdominal pressure, while its Sippi system provides digital, automated urine monitoring and biofilm control. The company was founded in 2009 and is headquartered in Oslo, Norway.
| Market Cap | $6.4M | Trading Days | 1554 |
| 52W High | 1.39 |
| 52W Low | 0.53 |
| % Off High | −22.30% |
| YTD | 45.95% | 1Y | −10.00% |
| 3Y | −87.10% | 5Y | −99.45% |
| Since incept. (ann.) | −46.47% |
| Ann. Volatility (1Y) | 104.63% | Ann. Volatility (3Y) | 131.43% |
| Sharpe (1Y) | 0.38 | Sharpe (3Y) | 0.10 |
| Max Drawdown (1Y) | −53.75% | Max Drawdown (3Y) | −97.30% |
| Beta (3Y, vs SPY) | −1.62 |
No same-industry peers in the universe for OBSRV.OL.
